找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunoconjugate Therapy of Hematologic Malignancies; Steven T. Rosen,Timothy M. Kuzel Book 1993 Springer Science+Business Media New York 1

[復(fù)制鏈接]
樓主: 五個
31#
發(fā)表于 2025-3-26 23:14:48 | 只看該作者
32#
發(fā)表于 2025-3-27 03:40:14 | 只看該作者
33#
發(fā)表于 2025-3-27 05:46:20 | 只看該作者
n hydrodynamics will require four assumptions in addition to the assumption that a small element of the fluid obeys Newton’s second law. Except for Sects. 4.5 and 4.6 this chapter will be concerned with the simplest cases, in which the . particles can be considered one at a time, each one obeying Ne
34#
發(fā)表于 2025-3-27 09:49:56 | 只看該作者
35#
發(fā)表于 2025-3-27 17:41:54 | 只看該作者
New approaches to radiolabeling monoclonal antibodies,njected dose per gram, localizes in tumor following intravenous injection [.]. The low tumor uptake in patients may be related to such factors as antibody dilution following injection [.], the slow rate of diffusion or penetration of antibody molecules across the vascular endothelium [.], and restricted blood flow in tumor tissue [.].
36#
發(fā)表于 2025-3-27 21:06:19 | 只看該作者
Immunotoxins for the therapy of graft versus host disease,ransplant therapy to those without such a donor through the use of bone marrow from mismatched related or matched unrelated donors. Once moderate to severe GVHD occurs, up to half of patients will die despite therapeutic intervention.
37#
發(fā)表于 2025-3-27 22:22:18 | 只看該作者
Radioimmunotherapy of lymphoma,, mention new obstacles to successful incorporation of radiolabeled MoAbs into standard oncologic therapy, and suggest future directions that may lead to enhanced effectiveness of radioimmunoconjugates.
38#
發(fā)表于 2025-3-28 04:14:35 | 只看該作者
Imaging and dosimetry determinations using radiolabeled antibodies, technology [.], the development of radiolabeled anti-tumor monoclonal antibodies (MoAb) as imaging and therapeutic reagents promises to add an element of specificity not previously available with conventional techniques.
39#
發(fā)表于 2025-3-28 08:15:59 | 只看該作者
40#
發(fā)表于 2025-3-28 12:30:40 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-26 12:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
罗山县| 平利县| 肥城市| 应用必备| 潮安县| 柞水县| 白玉县| 贵溪市| 忻州市| 民权县| 时尚| 利津县| 富川| 碌曲县| 望城县| 响水县| 锦屏县| 米易县| 广河县| 武夷山市| 霍林郭勒市| 台中县| 垣曲县| 黑水县| 泗水县| 阿拉尔市| 十堰市| 西城区| 林芝县| 开封县| 宜兰县| 南乐县| 轮台县| 新乡市| 普兰店市| 囊谦县| 旬邑县| 瓮安县| 昭通市| 鸡西市| 彝良县|